| 英文名称 |
中文名称 |
CAS |
MF |
| Deuterated Crosslinker DSP-d8 |
Deuterated Crosslinker DSP-d8 |
1639836-65-9 |
C14H8D8N2O8S2 |
| DI-FMOC-SELENO-L-CYSTINE |
DI-FMOC-SELENO-L-CYSTINE |
1639843-33-6 |
C36H32N2O8Se2 |
| (2E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one |
(2E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one |
1639856-62-4 |
C18H18O4 |
| 3-Amino-5-ethynylbenzoic acid |
3-AMINO-5-ETHYNYLBENZOIC ACID |
1639866-72-0 |
C9H7NO2 |
| (2R,5R)-2,5-DiMethylMorpholine hydrochloride |
2R,5R-二甲基吗啉盐酸盐 |
1639886-52-4 |
C6H14ClNO |
| tBID |
1639895-85-4 |
1639895-85-4 |
C11H3Br4N3O2 |
| (2S,5R)-2,5-diMethylMorpholine |
2S,5R-二甲基吗啉 |
1639924-58-5 |
C6H13NO |
| (2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
原研518-12 |
1639970-62-9 |
C22H23NO4 |
| TH588 (hydrochloride) |
1640282-30-9 |
1640282-30-9 |
C13H13Cl3N4 |
| I-CBP112 |
化合物I-CBP112 |
1640282-31-0 |
C27H36N2O5 |
| Oclacitinib maleate |
PF-03394197 |
1640292-55-2 |
C19H27N5O6S |
| (2R)-2-AMINO-2-(6-METHOXY(3-PYRIDYL))ETHAN-1-OL DIHYDROCHLORIDE |
1640848-71-0 |
1640848-71-0 |
C8H13ClN2O2 |
| (S)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride |
1640848-91-4 |
1640848-91-4 |
C8H14Cl2N2O2 |
| (R)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride |
1640848-93-6 |
1640848-93-6 |
C8H14Cl2N2O2 |
| 17878-A2 |
1640894-12-7 |
1640894-12-7 |
C26H22N2O5 |
| 17878-A3 |
1640894-15-0 |
1640894-15-0 |
C26H24N2O5 |
| (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid |
1640968-91-7 |
C28H35NO4 |
| Tofacitinib Impurity 77 |
托法替尼杂质 |
1640971-51-2 |
C16H20N6O2 |
| (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile |
托法替尼杂质 |
1640971-60-3 |
C14H20N6O |
| Tofacitinib Impurity 6 |
托法替尼杂质 6 |
1640972-35-5 |
C16H22N6O |
| 1H,3H-Furo[3,4-c]isoxazole, 6a-(5-bromo-2-fluorophenyl)tetrahydro-1-[(1R)-1-phenylpropyl]-, (3aS,6aS)- |
|
1640975-25-2 |
C20H21BrFNO2 |
| 2,6-bis[4-(diphenylamino)phenyl]- 9,10-Anthracenedione |
2,6-双[4-二苯胺基苯基]-9,10-蒽醌 |
1640978-33-1 |
C50H34N2O2 |
| 2-(4-Bromo-2-formylphenoxy)acetic acid |
((6-氯吡啶-2-基)甲基)氨基甲酸叔丁酯 |
1640995-60-3 |
C11H15ClN2O2 |
| 2-Ethoxy-5-(ethoxyMethyl)thiazole |
2-甲氧基-5-(乙氧基甲基)噻唑 |
1640995-61-4 |
C8H13NO2S |
| (2-Aminothiazol-5-yl)methanol hydrochloride |
(2-氨基噻唑-5-基)甲醇盐酸盐 |
1640995-62-5 |
C4H7ClN2OS |
| (4-Chloropyridin-2-yl)methanamine hydrochloride |
2-氨甲基-4-氯吡啶 |
1640995-63-6 |
C6H8Cl2N2 |
| tert-butyl4-((2S,5S)-1-((4-nitrophenyl)sulfonyl)-5-(((4-nitrophenyl)sulfonyl)oxy)piperidine-2-carboxamido)piperidine-1-carboxylate |
|
1640998-70-4 |
C28H35N5O12S2 |
| Methyl 4-cyano-2-(trifluoromethyl)benzoate |
4-氰基-2-(三氟甲基)苯甲酸甲酯 |
1641588-74-0 |
C10H6F3NO2 |
| Alfacalcidol-D6 |
阿尔法骨化醇-D6 |
1641940-94-4 |
C27H44O2 |
| Mavacamten |
玛伐凯泰 |
1642288-47-8 |
C15H19N3O2 |
| SRN-927) |
1642297-01-5 |
1642297-01-5 |
C28H28FNO4 |
| 3-(fluoromethyl)azetidine hydrochloride |
3-(氟甲基)氮杂环丁烷盐酸盐 |
1642298-59-6 |
C4H9ClFN |
| KPT-8602 |
CS-2388 |
1642300-52-4 |
C17H10F6N6O |
| KPT-8602 (Z-isomer) |
1642300-78-4 |
1642300-78-4 |
C17H10F6N6O |
| PDE1-IN-1 (phosphate) |
1642303-38-5 |
1642303-38-5 |
C29H29FN7O5P |
| 22-(tert-Butoxy)-22-oxodocosanoic acid |
22-(叔丁氧基)-22-氧代二十烷酸 |
1642333-05-8 |
C26H50O4 |
| 4,7-dibromo-5,6-bis((2-ethylhexyl)oxy)benzo[c][1,2,5]thiadiazole |
PM241 |
1642535-94-1 |
C22H34Br2N2O2S |
| Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
氯唑西林EP杂质B |
1642559-64-5 |
C18H20ClN3O4S |
| (S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1642571-07-0 |
C22H22N6O |
| Glumetinib |
谷美替尼 |
1642581-63-2 |
C21H17N9O2S |
| 1-Isopropyl-4-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-1,2,3,6-tetrahydro-pyridine |
1-异丙基-4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-1,2,3,6-四氢吡啶 |
1642583-50-3 |
C14H26BNO2 |
| AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO |
阿莫西林杂质D |
1642629-94-4 |
C16H21N3O6S |
| (DES-PYR1)-LEUPROLIDE |
(DES-PYR1,DES-GLY10,D-LEU6,PRO-NHET9)-LHRH |
1642799-35-6 |
C54H79N15O10 |
| 6-broMo-5-(trifluoroMethyl)pyridin-3-aMine |
6-溴-5-(三氟甲基)吡啶-3-胺 |
1642844-33-4 |
C6H4BrF3N2 |
| Dabigatran iMpurity F |
达比加群杂质F |
1642853-67-5 |
C19H20N4O4 |
| 2-ALLYLOXY-BENZALDEHYDE OXIME |
|
1642857-43-9 |
C10H11NO2 |
| TLR7-IN-1 |
CS-2748 |
1642857-69-9 |
C17H16N6O2 |
| N-Propylsulfuric diamide-sodium |
丙胺基磺酰胺钠盐 |
1642873-03-7 |
C3H11N2NaO2S |
| Macitentan Impurity 11 |
马西替坦杂质11 |
1642873-04-8 |
C12H10BrClN2O2 |
| tert-butyl 2-oxo-1-oxa-3,7-diazaspiro[4.4]nonane-7-carboxylate |
叔-丁基 2-氧亚基-1-氧杂-3,7-二氮杂螺[4.4]壬烷-7-甲酸基酯 |
1642899-83-9 |
C11H18N2O4 |
| SAfit2 |
1643125-33-0 |
1643125-33-0 |
C46H62N2O10 |
| (R)-2-(1-(2-(bis(tert-butoxycarbonyl)amino)-5-bromopyridin-3-yloxy)ethyl)-4-fluorobenzoicacid |
|
1643141-17-6 |
C24H28BrFN2O7 |
| 4-broMo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride |
4-BROMO-5-FLUORO-2-HYDRAZINYLBENZOIC ACID HYDROCHLORIDE |
1643156-18-6 |
C7H7BrClFN2O2 |
| (S)-5-bromo-6-fluoro-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide |
1643156-23-3 |
1643156-23-3 |
C16H18BrFN2O2 |
| 5-Bromo-2-iodo-4-methyl-phenylamine |
5-Bromo-2-iodo-4-methyl-phenylamine |
1643156-27-7 |
C7H7BrIN |
| 15406-A3 |
|
1643177-29-0 |
C11H12O |
| 5-chloro-N-(4-(5-morpholino-6-oxo-3,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide |
5-氯-N-(4-(3-吗啉代-2-氧代-5,6-二氢吡啶-1(2H)-基)苯基)戊酰胺 |
1643330-62-4 |
C20H26ClN3O3 |
| BMS-986142 |
BMS986142 |
1643368-58-4 |
C32H30F2N4O4 |
| Dabigatran Etexilate iMpurity |
达比加群酯杂质 |
1643377-48-3 |
C25H26N8O2 |
| Ticagrelor Impurity N |
替格瑞洛杂质N |
1643378-47-5 |
C23H29FN6O4S |
| Ticagrelor Impurity 15 |
替格瑞洛杂质15 |
1643378-48-6 |
C23H28F2N6O4S |
| Dabigatran Etexilate iMpurity G |
达比加群酯杂质G |
1643392-59-9 |
C41H55N7O8 |
| 3-BROMO-N'-HYDROXYBENZENECARBOXIMIDAMIDE |
(Z)-3-溴基-N'-羟基苯甲 |
1643440-91-8 |
C7H7BrN2O |
| (4-(4,6-diphenylpyridin-2-yl)phenyl)boronic acid |
(4-(4,6-二苯基吡啶-2-基)苯基)硼酸 |
1643448-23-0 |
C23H18BNO2 |
| 2-(5-Chloro-2-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2-(5-Chloro-2-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
1643467-83-7 |
C13H15BClF3O3 |
| 9-[1,1'-Biphenyl]-3-yl-9'-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole |
N-(3-联苯基)-N-(4-联苯基)-3,3-双咔唑 |
1643479-47-3 |
C48H32N2 |
| 1,3-di-tert-butyl-5-heptylbenzene |
1,3-DI-TERT-BUTYL-5-HEPTYLBENZENE |
1643540-34-4 |
C21H36 |
| (R)-6-Fluoro-2-(piperidin-3-yl)isoindolin-1-one hydrochloride |
|
1643571-00-9 |
C13H16ClFN2O |
| benzyl 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate |
噻嗪二酮 |
1643573-74-3 |
C19H26BNO4 |
| tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopent-3-en-1-yl)carbamate |
1643574-07-5 |
1643574-07-5 |
C16H28BNO4 |
| Acid-PEG13-NHS ester |
ACID-PEG13-NHS ESTER |
1643594-31-3 |
(C2H4O)nC10H13NO7 |
| 9H-Fluoren-9-ol, 9-(4-dibenzofuranyl)- |
9-(4-二苯并呋喃基)-9H-芴-9-醇 |
1643678-96-9 |
C25H16O2 |
| Atomoxetine EP Impurity C HCl |
托莫西汀EP杂质C盐酸盐 |
1643684-06-3 |
C17H21NO |
| 4-(2-Benzoxazolyl)-N-phenylbenzenamine |
3,3'-二羟基联苯胺 |
1643848-13-8 |
C19H14N2O |
| 19-(tert-Butoxy)-19-oxononadecanoic acid |
十九烷二酸单叔丁酯 |
1643852-37-2 |
C23H44O4 |
| KPT-9294 |
KPT-9274 |
1643913-93-2 |
C35H29F3N4O3 |
| 4-((5-bromo-2-fluorophenyl)sulfonyl)morpholine |
4-((5-溴-2-氟苯基)磺酰)吗啉 |
1643915-62-1 |
C10H11BrFNO3S |
| 1-methyl-4-{1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl}piperazine |
1-methyl-4-{1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl}piperazine |
1643923-77-6 |
C20H31BN2O2 |
| 9,9-Dimethyl-10-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-9,10-dihydro-acridine |
9,9-Dimethyl-10-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-9,10-dihydro-acridine |
1643935-09-4 |
C27H30BNO2 |
| Tos-PEG2-CH2CO2tBu |
2-(2-(对甲苯磺酰氧基)乙氧基)乙酸叔丁酯 |
1643957-24-7 |
C15H22O6S |
| Benzyl-PEG3-CH2CO2tBu |
苄基-PEG3-乙酸叔丁酯 |
1643957-26-9 |
C17H26O5 |
| 3-AMINO-4-PHENYLPYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
(3S,4R)-3-氨基-4-苯基吡咯烷-1-羧酸叔丁酯 |
1643979-48-9 |
C15H22N2O2 |
| 5-Methoxy-4-((4-Methoxybenzyl)oxy)-2-nitrobenzoic acid |
5-甲氧基-4-((4-甲氧基苄基)氧基)-2-硝基苯甲酸 |
1643979-88-7 |
C16H15NO7 |
| 3-(9,9-dimethylacridin-10(9H )-yl)-9H -xanthen-9-one |
3-(9- 9-二甲基嘧啶-10(9H)-基)-9H-黄嘌呤-9-酮 |
1643983-89-4 |
C28H21NO2 |
| N-(9,9-dimethyl-9H-fluoren-4-yl)-9,9-dimethyl-9H-fluoren-2-amine |
N-(9,9-二甲基-9H-芴-4-基)-9,9-二甲基-9H-芴-2-胺 |
1644054-07-8 |
C30H27N |
| N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine |
N-(4-溴苯基)-9,9-二甲基-9H-芴-2-胺 |
1644059-09-5 |
C21H18BrN |
| Fumarate hydratase-IN-1 |
Fumarate hydratase 抑制剂1 |
1644060-37-6 |
C27H30N2O4 |
| 7-Methoxy-imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester |
7-甲氧基咪唑并[1,2-A]吡啶-3-甲酸乙酯 |
1644071-15-7 |
C11H12N2O3 |
| 1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene |
[1-(4-丙炔氧基苯基)-1,2,2-三苯基]乙烯 |
1644078-88-5 |
C29H22O |
| benzyl 4-hydrazinylpiperidine-1-carboxylate dihydrochloride(WXC02324) |
苯甲基 4-肼基哌啶-1-甲酸基酯二盐酸 |
1644088-97-0 |
C13H20ClN3O2 |
| Acid Ceramidase Inhibitor 17a |
ARN14974 |
1644158-57-5 |
C24H21FN2O3 |
| Azido-PEG10-acid |
叠氮-十聚乙二醇-羧酸 |
1644163-57-4 |
C23H45N3O12 |
| PffBT4T-2OD |
P1140 |
1644164-62-4 |
(C62H88F2N2S5)n |
| MPEG6-Mal |
甲基-PEG6-琥珀酰亚胺 |
1644231-07-1 |
C20H34N2O9 |
| ethyl 2-hydroxy-5,6,7,8-tetrahydro-1,6-naphthyridine-5-carboxylate hydrochloride |
2-羟基-5,6,7,8-四氢-1,6-萘啶-5-羧酸乙酯 盐酸盐 |
1644236-95-2 |
C11H15ClN2O3 |
| (12-oxo-5,6,11,12-tetrahydrobenzo[6,7]azepino[4,3-b]indole-4,10-diyl)bis((4-bromophenyl)methanone) |
溴芬酸杂质3 |
1644279-16-2 |
C30H18Br2N2O3 |
| 6-Bromo-3,4-difluoro-2-nitrophenol |
|
1644281-87-7 |
C6H2BrF2NO3 |
| Pemetrexed disodium Ketone impurity |
培美曲塞杂质7 |
1644287-27-3 |
C20H21N5O7 |
| (1S,4R)-3-((((1R,2R)-2-((4-(1-oxidobenzo[d]isothiazol-3-yl) piperazin-1-yl)methyl)cyclohexyl)methyl)carbamoyl)bicycle [2.2.1]heptane-2-carboxylic acid |
鲁拉西酮杂质24 |
1644295-07-7 |
C28H38N4O3S |
| MAVBUKOHERNHBQ-UHFFFAOYSA-N |
鲁拉西酮杂质砜 |
1644295-09-9 |
C28H36N4O4S |
